Mitogen-activated protein kinase blockade in melanoma: intermittent versus continuous therapy, from preclinical to clinical data.

Tétu P, Vercellino L, Reger de Moura C, Baroudjian B, Dumaz N, Mourah S, Lebbé C

DOI: 10.1097/cco.0000000000000706
Published: 2021 Mar 1
Container: Current opinion in oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/cco.0000000000000706,
  title = {Mitogen-activated protein kinase blockade in melanoma: intermittent versus continuous therapy, from preclinical to clinical data.},
  author = {Tétu P and Vercellino L and Reger de Moura C and Baroudjian B and Dumaz N and Mourah S and Lebbé C},
  year = {2021},
  journal = {Current opinion in oncology},
  doi = {10.1097/cco.0000000000000706},
  url = {https://doi.org/10.1097/cco.0000000000000706}
}

RIS

TY  - JOUR
TI  - Mitogen-activated protein kinase blockade in melanoma: intermittent versus continuous therapy, from preclinical to clinical data.
AU  - Tétu P
AU  - Vercellino L
AU  - Reger de Moura C
AU  - Baroudjian B
AU  - Dumaz N
AU  - Mourah S
AU  - Lebbé C
PY  - 2021
JO  - Current opinion in oncology
DO  - 10.1097/cco.0000000000000706
UR  - https://doi.org/10.1097/cco.0000000000000706
ER  -

APA

P, T., L, V., C, R. D. M., B, B., N, D., S, M., & C, L. (2021). Mitogen-activated protein kinase blockade in melanoma: intermittent versus continuous therapy, from preclinical to clinical data.. Current opinion in oncology. https://doi.org/10.1097/cco.0000000000000706

Source records

pubmed · retrieved 2026-09-27T16:00:51.655Z